2,5-Dioxopyrrolidin-1-yl 2,2-dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azaheptadecan-17-oate, 95%, 10g

ethyl 6-Bromo-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 96%, 100mg

4-Methylumbelliferyl beta-D-Ribofuranoside>98.0%(HPLC)100mg

Nitric acid, 65%, pure, 2.5 l, glass packaging

(R)-1-(5-Chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride, 98%, 10mg

tert-Butyl 3-(2-(tosyloxy)ethoxy)propanoate, 95%, 1g

1-(4-Benzyloxyphenyl)ethylamine, 98.0%, 1g

2-Methyl-2-(piperidin-1-yl)propanoic acid, 98%, 500mg

Methyl 5-(2-bromoacetyl)thiophene-2-carboxylate, 95+%, 1g

6-Bromoisoquinoline-3-carboxylic acid, 95.0%, 1g

Methyl 4-biphenylcarboxylate, 99.0%, 1g

2,5-Dihydroxy-3-undecyl-[1,4]benzoquinone, 97.0%, 250mg

1-(3-nitrophenyl)piperidin-2-one, 98.0%, 100mg